Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer

Condition:   Nasopharyngeal Cancer
Intervention:   Drug: Avelumab
Sponsors:   Assuntina Sacco, M.D.;   Pfizer
Not yet recruiting - verified August 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2bdAYKv
via IFTTT